127 related articles for article (PubMed ID: 19859022)
1. Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.
Erlewyn-Lajeunesse M; Walker W; Basarab A; Eren E; Afzal N; Godfrey K; Faust SN
Pediatr Infect Dis J; 2009 Nov; 28(11):1036-7. PubMed ID: 19859022
[No Abstract] [Full Text] [Related]
2. Liver abscess caused by an infected ventriculoperitoneal shunt: doubtful etiology and time for an alternative to vancomycin.
Chang WN; Lu CH; Huang CR
J Formos Med Assoc; 2003 Jun; 102(6):435; author reply 436. PubMed ID: 12923599
[No Abstract] [Full Text] [Related]
3. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
[TBL] [Abstract][Full Text] [Related]
5. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
6. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
[No Abstract] [Full Text] [Related]
7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
8. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Beeck VO; Dhif N; Philipp J; De Bels D
J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
[No Abstract] [Full Text] [Related]
9. Linezolid treatment of a prosthetic joint infection with Staphylococcus lugdunensis in a patient with multiple myeloma.
Merino P; Arribi A; Gestoso I; Picazo J; Gimeno L; Del Potro E
Int J Antimicrob Agents; 2010 Feb; 35(2):203-4. PubMed ID: 19942414
[No Abstract] [Full Text] [Related]
10. Linezolid in postneurosurgical infections.
Maure B; Martínez-Vázquez C; Argibay A; Pérez-Veloso M; Rodríguez Fernández MJ; Sopeña B
Infection; 2008 Feb; 36(1):82-3. PubMed ID: 18165859
[No Abstract] [Full Text] [Related]
11. Linezolid to decrease length of stay in the hospital for patients with methicillin-resistant Staphylococcus aureus infection.
Siegel RE
Clin Infect Dis; 2003 Jan; 36(1):124; author reply 124-5. PubMed ID: 12491215
[No Abstract] [Full Text] [Related]
12. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Wegner DL
MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
[No Abstract] [Full Text] [Related]
13. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
[TBL] [Abstract][Full Text] [Related]
14. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
15. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G; Lange C; Richardson MD; Matteelli A; Centis R; Eker B; Guenther G; Spanevello A; Migliori GB;
J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
[No Abstract] [Full Text] [Related]
16. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
[TBL] [Abstract][Full Text] [Related]
17. Linezolid resistance in three isolates of coagulase-negative staphylococci.
Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
[No Abstract] [Full Text] [Related]
18. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid.
Mogenet I; Raetz-Dillon S; Canonge JM; Archambaud M; Bonnet E
Ann Pharmacother; 2004 Jun; 38(6):986-8. PubMed ID: 15113981
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
20. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
Nathwani D
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii37-44. PubMed ID: 12730141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
